Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02631538
What this trial is testing

Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
GlaxoSmithKline 86
Post-approval studies (Phase 4)Looking for participantsNCT06410833
What this trial is testing

Belimumab After Rituximab in Resistant Primary Juvenile SS

Who this might be right for
Sjogren's SyndromePediatric ALL
Peking Union Medical College Hospital 15
Not applicableUnknownNCT05659407
What this trial is testing

BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisBLyS Polymorphism
University of Cagliari 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05069051
What this trial is testing

Belimumab in Patients with Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphoid Leukemia in Relapse
University Hospital Tuebingen 120
Testing effectiveness (Phase 2)Study completedNCT00071487
What this trial is testing

Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Lupus Erythematosus, Systemic
Human Genome Sciences Inc. 449
Testing effectiveness (Phase 2)Study completedNCT01649765
What this trial is testing

Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 93
Testing effectiveness (Phase 2)Ended earlyNCT01025193
What this trial is testing

Desensitization With Belimumab in Sensitized Patients Awaiting Kidney Transplant

Who this might be right for
Desensitization
University of Pennsylvania 8
Large-scale testing (Phase 3)Study completedNCT00712933
What this trial is testing

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 738
Testing effectiveness (Phase 2)Study completedNCT02260934
What this trial is testing

Rituximab and Belimumab for Lupus Nephritis

Who this might be right for
Lupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID) 43
Testing effectiveness (Phase 2)Study completedNCT01480596
What this trial is testing

The Evaluation of Belimumab in Myasthenia Gravis (MG)

Who this might be right for
Myasthaenia Gravis
GlaxoSmithKline 40
Post-approval studies (Phase 4)Active Not RecruitingNCT06411249
What this trial is testing

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 303
Post-approval studies (Phase 4)Study completedNCT04956484
What this trial is testing

Belimumab In Early Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Peking Union Medical College Hospital 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04179032
What this trial is testing

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 25
Not applicableNo Longer AvailableNCT03125486
What this trial is testing

Compassionate Use for Subcutaneous (SC) Belimumab

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT03312907
What this trial is testing

Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 292
Not applicableUnknownNCT06327724
What this trial is testing

Belimumab in SLE Synovial Inflammation and Lymph Nodes

Who this might be right for
Systemic Lupus Erythematosus
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 15
Not applicableLooking for participantsNCT06527872
What this trial is testing

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

Who this might be right for
Lupus Nephritis
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Ended earlyNCT04767698
What this trial is testing

Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 4
Not applicableNo Longer AvailableNCT00931086
What this trial is testing

Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99

Who this might be right for
Rheumatoid Arthritis
Human Genome Sciences Inc., a GSK Company
Large-scale testing (Phase 3)Study completedNCT00424476
What this trial is testing

Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 865
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation